{"id":833215,"date":"2025-04-02T16:30:54","date_gmt":"2025-04-02T20:30:54","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-present-at-upcoming-healthcare-conference-in-april\/"},"modified":"2025-04-02T16:30:54","modified_gmt":"2025-04-02T20:30:54","slug":"curis-to-present-at-upcoming-healthcare-conference-in-april","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-present-at-upcoming-healthcare-conference-in-april\/","title":{"rendered":"Curis to Present at Upcoming Healthcare Conference in April"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">LEXINGTON, Mass.<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">April 2, 2025<\/span><\/span> \/PRNewswire\/ &#8212; Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that <span class=\"xn-person\">James Dentzer<\/span>, President and Chief Executive Officer of Curis, will participate in the Jones Healthcare and Technology Innovation Conference on <span class=\"xn-chron\">Wednesday, April 9, 2025<\/span> with a fireside chat and company presentation.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/607886\/Curis_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/607886\/Curis_Logo.jpg\" title=\"(PRNewsfoto\/Curis, Inc.)\" alt=\"(PRNewsfoto\/Curis, Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>All Bets on IRAK4 Fireside Chat:<\/p>\n<ul type=\"disc\">\n<li>Time: <span class=\"xn-chron\">4:30 pm ET<\/span> (<span class=\"xn-chron\">1:30 pm PT<\/span>)<\/li>\n<li>\n          <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4397684-1&amp;h=1831857664&amp;u=https%3A%2F%2Fnam11.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Ftwst-dot-yamm-track.appspot.com%252F245Fzg_EtEibe36gKIYG0hQh5-BWXQ5K4e_JmbCFKDGnaKIz3lQFHs8Y0LL6JNo-098Uj_mE9THD0hb1_SZ6Su2OZcRzClyPAKXtWzZlJbv5KZblgUhq6d6N6lTYA_OmLuwPVAhW9FnwClfZGf1tEIDcd0ijhFNMLjqLR35YI9KHQ9mUVYsw5wSAn6gVGrPa90EPYKayNodo%26data%3D05%257C02%257Cdduvall%2540curis.com%257Cae178a5364e34dae9cb008dd720bcc8c%257C931fcb9603b14c758b7a61cf37803cb8%257C0%257C0%257C638792117226731085%257CUnknown%257CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%253D%253D%257C4000%257C%257C%257C%26sdata%3D9UsD5W8mdekG0J5rDXLVbd48MytA%252FO3YsYTRTUrXJ5U%253D%26reserved%3D0&amp;a=Fireside+Chat+Webcast\" target=\"_blank\" rel=\"nofollow\">Fireside Chat Webcast<\/a>\n        <\/li>\n<\/ul>\n<p>Curis Company Presentation:<\/p>\n<ul type=\"disc\">\n<li>Time: <span class=\"xn-chron\">5:00 pm ET<\/span> (<span class=\"xn-chron\">2:00 pm PT<\/span>)<\/li>\n<li>\n          <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4397684-1&amp;h=898744594&amp;u=https%3A%2F%2Fnam11.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwsw.com%252Fwebcast%252Fjones2%252Fcris%252F1889729%26data%3D05%257C02%257Cdduvall%2540curis.com%257C7bd5d74ad51f487c128008dd7217eca6%257C931fcb9603b14c758b7a61cf37803cb8%257C0%257C0%257C638792169315206552%257CUnknown%257CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%253D%253D%257C4000%257C%257C%257C%26sdata%3DRhCqcjJ9uqVywHOXT2GzcMSM6SMgxRENoX0LyNbHi1k%253D%26reserved%3D0&amp;a=Corporate+Presentation+Webcast\" target=\"_blank\" rel=\"nofollow\">Corporate Presentation Webcast<\/a>\n        <\/li>\n<\/ul>\n<p>The live webcast and archived replay will be available and can also be accessed from the <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4397684-1&amp;h=3769353756&amp;u=https%3A%2F%2Finvestors.curis.com%2Fevents-and-presentations&amp;a=Events+%26+Presentations\" target=\"_blank\" rel=\"nofollow\">Events &amp; Presentations<\/a>\u00a0section of Curis&#8217;s website.<\/p>\n<p>\n        <b>About Curis, Inc.<\/b>\n      <\/p>\n<p>Curis is a biotechnology company focused on the development of emavusertib, an orally available, small molecule IRAK4 inhibitor. Emavusertib is currently being evaluated in the Phase 1\/2 TakeAim Lymphoma study (CA-4948-101)\u00a0in patients with relapsed\/refractory primary central nervous system lymphoma (PCNSL) in combination with the BTK inhibitor ibrutinib, as a monotherapy in the Phase 1\/2 TakeAim Leukemia study (CA-4948-102) in patients with relapsed\/refractory acute myeloid leukemia (AML) and relapsed\/refractory high risk myelodysplastic syndrome (hrMDS), and as a frontline combination therapy with venetoclax and azacitidine in patents with AML (CA-4948-104). Emavusertib has received Orphan Drug Designation from the U.S. Food and Drug Administration for the treatment of PCNSL, AML and MDS and from the European Commission for the treatment of PCNSL.\u00a0Curis, through its 2015 collaboration with Aurigene, has the exclusive license to emavusertib (CA-4948). Curis licensed its rights to Erivedge\u00ae to Genentech, a member of the Roche Group, under which they are commercializing Erivedge\u00ae for the treatment of advanced basal cell carcinoma. For more information, visit Curis&#8217;s website at <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4397684-1&amp;h=354182120&amp;u=http%3A%2F%2Fwww.curis.com%2F&amp;a=www.curis.com\" target=\"_blank\" rel=\"nofollow\">www.curis.com<\/a>.\u00a0<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE56496&amp;sd=2025-04-02\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/curis-to-present-at-upcoming-healthcare-conference-in-april-302418986.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/curis-to-present-at-upcoming-healthcare-conference-in-april-302418986.html<\/a><\/p>\n<p>SOURCE  Curis, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NE56496&amp;Transmission_Id=202504021605PR_NEWS_USPR_____NE56496&amp;DateId=20250402\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire LEXINGTON, Mass. , April 2, 2025 \/PRNewswire\/ &#8212; Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that James Dentzer, President and Chief Executive Officer of Curis, will participate in the Jones Healthcare and Technology Innovation Conference on Wednesday, April 9, 2025 with a fireside chat and company presentation. All Bets on IRAK4 Fireside Chat: Time: 4:30 pm ET (1:30 pm PT) Fireside Chat Webcast Curis Company Presentation: Time: 5:00 pm ET (2:00 pm PT) Corporate Presentation Webcast The live webcast and archived replay will be available and can also be accessed from the Events &amp; Presentations\u00a0section of Curis&#8217;s website. About Curis, Inc. Curis &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-present-at-upcoming-healthcare-conference-in-april\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Curis to Present at Upcoming Healthcare Conference in April&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-833215","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Curis to Present at Upcoming Healthcare Conference in April - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-present-at-upcoming-healthcare-conference-in-april\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Curis to Present at Upcoming Healthcare Conference in April - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire LEXINGTON, Mass. , April 2, 2025 \/PRNewswire\/ &#8212; Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that James Dentzer, President and Chief Executive Officer of Curis, will participate in the Jones Healthcare and Technology Innovation Conference on Wednesday, April 9, 2025 with a fireside chat and company presentation. All Bets on IRAK4 Fireside Chat: Time: 4:30 pm ET (1:30 pm PT) Fireside Chat Webcast Curis Company Presentation: Time: 5:00 pm ET (2:00 pm PT) Corporate Presentation Webcast The live webcast and archived replay will be available and can also be accessed from the Events &amp; Presentations\u00a0section of Curis&#8217;s website. About Curis, Inc. Curis &hellip; Continue reading &quot;Curis to Present at Upcoming Healthcare Conference in April&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-present-at-upcoming-healthcare-conference-in-april\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-02T20:30:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/607886\/Curis_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-to-present-at-upcoming-healthcare-conference-in-april\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-to-present-at-upcoming-healthcare-conference-in-april\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Curis to Present at Upcoming Healthcare Conference in April\",\"datePublished\":\"2025-04-02T20:30:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-to-present-at-upcoming-healthcare-conference-in-april\\\/\"},\"wordCount\":312,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-to-present-at-upcoming-healthcare-conference-in-april\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/607886\\\/Curis_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-to-present-at-upcoming-healthcare-conference-in-april\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-to-present-at-upcoming-healthcare-conference-in-april\\\/\",\"name\":\"Curis to Present at Upcoming Healthcare Conference in April - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-to-present-at-upcoming-healthcare-conference-in-april\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-to-present-at-upcoming-healthcare-conference-in-april\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/607886\\\/Curis_Logo.jpg\",\"datePublished\":\"2025-04-02T20:30:54+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-to-present-at-upcoming-healthcare-conference-in-april\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-to-present-at-upcoming-healthcare-conference-in-april\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-to-present-at-upcoming-healthcare-conference-in-april\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/607886\\\/Curis_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/607886\\\/Curis_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-to-present-at-upcoming-healthcare-conference-in-april\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Curis to Present at Upcoming Healthcare Conference in April\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Curis to Present at Upcoming Healthcare Conference in April - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-present-at-upcoming-healthcare-conference-in-april\/","og_locale":"en_US","og_type":"article","og_title":"Curis to Present at Upcoming Healthcare Conference in April - Market Newsdesk","og_description":"PR Newswire LEXINGTON, Mass. , April 2, 2025 \/PRNewswire\/ &#8212; Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that James Dentzer, President and Chief Executive Officer of Curis, will participate in the Jones Healthcare and Technology Innovation Conference on Wednesday, April 9, 2025 with a fireside chat and company presentation. All Bets on IRAK4 Fireside Chat: Time: 4:30 pm ET (1:30 pm PT) Fireside Chat Webcast Curis Company Presentation: Time: 5:00 pm ET (2:00 pm PT) Corporate Presentation Webcast The live webcast and archived replay will be available and can also be accessed from the Events &amp; Presentations\u00a0section of Curis&#8217;s website. About Curis, Inc. Curis &hellip; Continue reading \"Curis to Present at Upcoming Healthcare Conference in April\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-present-at-upcoming-healthcare-conference-in-april\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-02T20:30:54+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/607886\/Curis_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-present-at-upcoming-healthcare-conference-in-april\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-present-at-upcoming-healthcare-conference-in-april\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Curis to Present at Upcoming Healthcare Conference in April","datePublished":"2025-04-02T20:30:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-present-at-upcoming-healthcare-conference-in-april\/"},"wordCount":312,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-present-at-upcoming-healthcare-conference-in-april\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/607886\/Curis_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-present-at-upcoming-healthcare-conference-in-april\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-present-at-upcoming-healthcare-conference-in-april\/","name":"Curis to Present at Upcoming Healthcare Conference in April - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-present-at-upcoming-healthcare-conference-in-april\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-present-at-upcoming-healthcare-conference-in-april\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/607886\/Curis_Logo.jpg","datePublished":"2025-04-02T20:30:54+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-present-at-upcoming-healthcare-conference-in-april\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-present-at-upcoming-healthcare-conference-in-april\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-present-at-upcoming-healthcare-conference-in-april\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/607886\/Curis_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/607886\/Curis_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-present-at-upcoming-healthcare-conference-in-april\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Curis to Present at Upcoming Healthcare Conference in April"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/833215","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=833215"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/833215\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=833215"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=833215"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=833215"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}